Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Long-Term Debt Repayments (2016 - 2025)

Mesa Laboratories' Long-Term Debt Repayments history spans 15 years, with the latest figure at $84.1 million for Q4 2025.

  • For Q4 2025, Long-Term Debt Repayments rose 791.34% year-over-year to $84.1 million; the TTM value through Dec 2025 reached $115.4 million, up 2576.51%, while the annual FY2025 figure was $44.3 million, N/A changed from the prior year.
  • Long-Term Debt Repayments for Q4 2025 was $84.1 million at Mesa Laboratories, up from $13.4 million in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $84.1 million in Q4 2025 and bottomed at -$54.7 million in Q3 2024.
  • The 5-year median for Long-Term Debt Repayments is $10.0 million (2021), against an average of $13.3 million.
  • The largest annual shift saw Long-Term Debt Repayments crashed 520.65% in 2024 before it surged 791.34% in 2025.
  • A 5-year view of Long-Term Debt Repayments shows it stood at $10.0 million in 2021, then decreased by 20.0% to $8.0 million in 2022, then grew by 12.5% to $9.0 million in 2023, then grew by 4.87% to $9.4 million in 2024, then surged by 791.34% to $84.1 million in 2025.
  • Per Business Quant, the three most recent readings for MLAB's Long-Term Debt Repayments are $84.1 million (Q4 2025), $13.4 million (Q3 2025), and $17.9 million (Q1 2025).